NO912870L - Blandinger for tildeling av medikamenter. - Google Patents

Blandinger for tildeling av medikamenter.

Info

Publication number: NO912870L
Authority: NO; Norway
Prior art keywords: medicines; allocation; mixtures; composition; active compound
Prior art date: 1989-02-25

Application number

NO91912870A

Other languages

English (en)

Other versions

NO301692B1 (no

NO912870D0 (no

Inventor

Lisbeth Illum

Original Assignee

Danbiosyst Uk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-25

Filing date

1991-07-23

Publication date

1991-07-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10652342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO912870(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-07-23 Application filed by Danbiosyst Uk filed Critical Danbiosyst Uk

1991-07-23 Publication of NO912870D0 publication Critical patent/NO912870D0/no

1991-07-23 Publication of NO912870L publication Critical patent/NO912870L/no

1997-12-01 Publication of NO301692B1 publication Critical patent/NO301692B1/no

Links

239000000203 mixture Substances 0.000 title abstract 3
239000003814 drug Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
239000000126 substance Substances 0.000 abstract 2
RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 abstract 1
102000055006 Calcitonin Human genes 0.000 abstract 1
108060001064 Calcitonin Proteins 0.000 abstract 1
229920001661 Chitosan Polymers 0.000 abstract 1
229920002307 Dextran Polymers 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
229960004015 calcitonin Drugs 0.000 abstract 1
239000006185 dispersion Substances 0.000 abstract 1
239000003623 enhancer Substances 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
239000004005 microsphere Substances 0.000 abstract 1
210000004877 mucosa Anatomy 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Otolaryngology (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO912870A 1989-02-25 1991-07-23 Bærersubstans for bruk med farmakologisk aktiv forbindelse og fremgangsmåte for fremstilling av en blanding omfattende en slik bærer NO301692B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB898904370A GB8904370D0 (en)	1989-02-25	1989-02-25	Liquid delivery compositions
PCT/GB1990/000291 WO1990009780A1 (en)	1989-02-25	1990-02-23	Drug delivery compositions

Publications (3)

Publication Number	Publication Date
NO912870D0 NO912870D0 (no)	1991-07-23
NO912870L true NO912870L (no)	1991-07-23
NO301692B1 NO301692B1 (no)	1997-12-01

Family

ID=10652342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO912870A NO301692B1 (no)	1989-02-25	1991-07-23	Bærersubstans for bruk med farmakologisk aktiv forbindelse og fremgangsmåte for fremstilling av en blanding omfattende en slik bærer

Country Status (10)

Country	Link
EP (1)	EP0460020B2 (no)
JP (1)	JP3306779B2 (no)
AT (1)	ATE104545T1 (no)
CA (1)	CA2045472C (no)
DE (1)	DE69008346T3 (no)
DK (1)	DK0460020T3 (no)
ES (1)	ES2055904T5 (no)
GB (1)	GB8904370D0 (no)
NO (1)	NO301692B1 (no)
WO (1)	WO1990009780A1 (no)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2099376A1 (en) *	1991-01-03	1992-07-04	Henry E. Auer	Stabilization of proteins by cationic biopolymers
US6582728B1 (en)	1992-07-08	2003-06-24	Inhale Therapeutic Systems, Inc.	Spray drying of macromolecules to produce inhaleable dry powders
WO1995024183A1 (en)	1994-03-07	1995-09-14	Inhale Therapeutic Systems	Methods and compositions for pulmonary delivery of insulin
US6051256A (en)	1994-03-07	2000-04-18	Inhale Therapeutic Systems	Dispersible macromolecule compositions and methods for their preparation and use
US6054462A (en) *	1994-04-13	2000-04-25	Janssen Pharmaceutica, N.V.	Intranasal antimigraine compositions
HRP950149A2 (en) *	1994-04-13	1997-06-30	Janssen Pharmaceutica Nv	Intranasal antimigrene composition
GB9416884D0 (en) *	1994-08-20	1994-10-12	Danbiosyst Uk	Drug delivery compositions
GB9419979D0 (en) *	1994-10-04	1994-11-16	Medeva Holdings Bv	Vaccine compositions
SE9403905D0 (sv) *	1994-11-14	1994-11-14	Astra Ab	New formulations
US5780014A (en) *	1995-04-14	1998-07-14	Inhale Therapeutic Systems	Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
JP3098401B2 (ja) *	1995-07-12	2000-10-16	株式会社エルティーティー研究所	経鼻投与用製剤
GB9522351D0 (en) *	1995-11-01	1996-01-03	Medeva Holdings Bv	Vaccine compositions
GB9525083D0 (en) *	1995-12-07	1996-02-07	Danbiosyst Uk	Vaccine compositions
US6184037B1 (en)	1996-05-17	2001-02-06	Genemedicine, Inc.	Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
JP3020141B2 (ja) *	1996-10-07	2000-03-15	株式会社富士薬品	経鼻投与用製剤
US5968895A (en) *	1996-12-11	1999-10-19	Praecis Pharmaceuticals, Inc.	Pharmaceutical formulations for sustained drug delivery
GB9700624D0 (en)	1997-01-14	1997-03-05	Danbiosyst Uk	Drug delivery composition
US6730735B2 (en)	1997-07-03	2004-05-04	West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited	Conjugate of polyethylene glycol and chitosan
GB9725084D0 (en)	1997-11-28	1998-01-28	Medeva Europ Ltd	Vaccine compositions
IL140669A0 (en) *	1998-07-08	2002-02-10	Kirin Amgen Inc	Powdery preparation for mucosal administration containing polymeric medicine
GB0208742D0 (en)	2002-04-17	2002-05-29	Bradford Particle Design Ltd	Particulate materials
ATE375786T1 (de)	2001-08-16	2007-11-15	Cmp Therapeutics Ltd	Chitin-mikropartikel und ihre medizinische verwendung
CA2466020A1 (en) *	2001-09-28	2003-04-10	University Of South Florida	Rsv gene expression vaccine
US7666876B2 (en)	2002-03-19	2010-02-23	Vernalis (R&D) Limited	Buprenorphine formulations for intranasal delivery
US7582284B2 (en)	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
AU2003225281A1 (en)	2002-04-30	2003-11-17	University Of South Florida	Materials and methods for prevention and treatment of rna viral diseases
US9339459B2 (en)	2003-04-24	2016-05-17	Nektar Therapeutics	Particulate materials
US7595303B1 (en)	2002-09-05	2009-09-29	University Of South Florida	Genetic adjuvants for immunotherapy
GB0300531D0 (en)	2003-01-10	2003-02-12	West Pharm Serv Drug Res Ltd	Pharmaceutical compositions
GB0310919D0 (en)	2003-05-13	2003-06-18	West Pharm Serv Drug Res Ltd	Pharmaceutical compositions
GB0315632D0 (en)	2003-07-04	2003-08-13	West Pharm Serv Drug Res Ltd	Pharmaceutical formulations
WO2005092301A1 (en)	2004-03-26	2005-10-06	Universita' Degli Studi Di Parma	Insulin highly respirable microparticles
US8399025B2 (en)	2004-06-04	2013-03-19	Board Of Regents, The University Of Texas System	Polyamine modified particles
EP1797870A1 (en) *	2005-12-14	2007-06-20	The Jordanian Pharmaceutical Manufacturing Co.	Oral delivery of protein drugs using microemulsion
CN105853394A (zh)	2006-03-30	2016-08-17	恩根尼公司	用于体内转染肠细胞的非病毒组合物和方法
WO2007148048A1 (en)	2006-06-20	2007-12-27	Cmp Therapeutics Limited	Compositions comprising chitin microparticles and their medical uses
EP2120875B1 (en)	2007-02-11	2018-07-11	Map Pharmaceuticals Inc.	Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
AU2008289225A1 (en) *	2007-08-17	2009-02-26	Amgen Inc.	Formulations of antibodies and Fc-fusion molecules using polycations
EP2077132A1 (en)	2008-01-02	2009-07-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Dispensing device, storage device and method for dispensing a formulation
GB0812742D0 (en)	2008-07-11	2008-08-20	Critical Pharmaceuticals Ltd	Process
JP5670421B2 (ja)	2009-03-31	2015-02-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	コンポーネント表面のコーティング方法
EP2432531B1 (de)	2009-05-18	2019-03-06	Boehringer Ingelheim International GmbH	Adapter, inhalationseinrichtung und zerstäuber
WO2011064164A1 (en)	2009-11-25	2011-06-03	Boehringer Ingelheim International Gmbh	Nebulizer
US10016568B2 (en)	2009-11-25	2018-07-10	Boehringer Ingelheim International Gmbh	Nebulizer
JP5658268B2 (ja)	2009-11-25	2015-01-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ネブライザ
WO2011160932A1 (en)	2010-06-24	2011-12-29	Boehringer Ingelheim International Gmbh	Nebulizer
EP2694220B1 (de)	2011-04-01	2020-05-06	Boehringer Ingelheim International GmbH	Medizinisches gerät mit behälter
US9827384B2 (en)	2011-05-23	2017-11-28	Boehringer Ingelheim International Gmbh	Nebulizer
CA2859273C (en) *	2012-03-15	2020-04-14	Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.	Glycogen-based cationic polymers
WO2013152894A1 (de)	2012-04-13	2013-10-17	Boehringer Ingelheim International Gmbh	Zerstäuber mit kodiermitteln
WO2014055825A1 (en)	2012-10-04	2014-04-10	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	A formulation of mycobacterial components as an adjuvant for inducing th17 responses
WO2014113541A1 (en)	2013-01-16	2014-07-24	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Attenuated chlamydia vaccine
EP3030298B1 (en)	2013-08-09	2017-10-11	Boehringer Ingelheim International GmbH	Nebulizer
PL2835146T3 (pl)	2013-08-09	2021-04-06	Boehringer Ingelheim International Gmbh	Nebulizator
LT4242916T (lt)	2014-05-07	2025-12-29	Boehringer Ingelheim International Gmbh	Purkštuvas
EA032850B1 (ru)	2014-05-07	2019-07-31	Бёрингер Ингельхайм Интернациональ Гмбх	Контейнер, небулайзер и способ изготовления контейнера
ES2874029T3 (es)	2014-05-07	2021-11-04	Boehringer Ingelheim Int	Nebulizador

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3250023T (no) *	1981-01-14	1990-03-29

1989
- 1989-02-25 GB GB898904370A patent/GB8904370D0/en active Pending
1990
- 1990-02-23 DE DE69008346T patent/DE69008346T3/de not_active Expired - Lifetime
- 1990-02-23 WO PCT/GB1990/000291 patent/WO1990009780A1/en not_active Ceased
- 1990-02-23 DK DK90903612.1T patent/DK0460020T3/da active
- 1990-02-23 EP EP90903612A patent/EP0460020B2/en not_active Expired - Lifetime
- 1990-02-23 ES ES90903612T patent/ES2055904T5/es not_active Expired - Lifetime
- 1990-02-23 AT AT9090903612T patent/ATE104545T1/de not_active IP Right Cessation
- 1990-02-23 CA CA002045472A patent/CA2045472C/en not_active Expired - Lifetime
- 1990-02-23 JP JP50363790A patent/JP3306779B2/ja not_active Expired - Lifetime
1991
- 1991-07-23 NO NO912870A patent/NO301692B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69008346T3 (de)	1998-01-08
EP0460020A1 (en)	1991-12-11
DE69008346T2 (de)	1994-08-25
ATE104545T1 (de)	1994-05-15
ES2055904T5 (es)	1998-01-01
NO301692B1 (no)	1997-12-01
CA2045472C (en)	2000-01-04
NO912870D0 (no)	1991-07-23
GB8904370D0 (en)	1989-04-12
DK0460020T3 (da)	1994-05-16
EP0460020B2 (en)	1997-09-17
ES2055904T3 (es)	1994-09-01
DE69008346D1 (de)	1994-05-26
JP3306779B2 (ja)	2002-07-24
EP0460020B1 (en)	1994-04-20
WO1990009780A1 (en)	1990-09-07
CA2045472A1 (en)	1990-08-26

Publication	Publication Date	Title
NO912870D0 (no)	1991-07-23	Blandinger for tildeling av medikamenter.
AU3881989A (en)	1990-01-25	New solid porous unitary form comprising micro-particles and/or nano-particles, and its preparation
BR9911070A (pt)	2001-02-06	Sistema de liberação de droga compreendendo uma matéria-prima de medicamento sólido acentuadamente compacto
ATE332126T1 (de)	2006-07-15	Geschmacksmaskierte pharmazeutische zusammensetzungen
DE3779933D1 (de)	1992-07-30	Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung.
IL114596A (en)	2000-02-29	Pharmaceutical compositions containing an active substance blended with a carrier process for preparation thereof and their use for preparation of inhalated drugs
AU587281B2 (en)	1989-08-10	Slow-release pharmaceutical agent
ATE128863T1 (de)	1995-10-15	Arzneimittelformulierungen mit verzögerter wirkstoffabgabe.
MY101784A (en)	1992-01-17	Novel pharmacological compounds
IL96276A0 (en)	1991-08-16	Transdermal delivery system of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
JO1502B1 (en)	1989-01-25	New pharmacy vehicles
CS653586A3 (en)	1992-10-14	Pharmaceutical containing 7-isopropoxyisoflavone
KR900004325A (ko)	1990-04-12	유핵 과립 및 그의 제조방법
ES2171469T3 (es)	2002-09-16	Composicion administrada por via nasal y preparacion que la contiene.
DE3765243D1 (de)	1990-10-31	Ibuprofen und codein enthaltende, stabile, feste arzneimittel.
BR9809268A (pt)	2000-06-27	Unidade de dosagem farmacêutica, processo para fabricação da mesma, e, uso de um produto de amido como um veìculo para unidades de dosagem farmacêutica compreendendo tibolona
ES2059312T3 (es)	1994-11-16	Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
MY102411A (en)	1992-06-17	Nasal solutions
EE9600202A (et)	1997-06-16	Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm
BR0012775A (pt)	2002-04-02	Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido
DE69225053D1 (de)	1998-05-14	Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung
ES2058065T3 (es)	1994-11-01	Composiciones farmaceuticas que contienen fragmentos de acth para la terapia de condiciones de shock y de insuficiencias respiratorias y cardiocirculatorias.
BG103023A (en)	2000-06-30	Bronchodilatation medicamentous form
KR920016104A (ko)	1992-09-24	노인성 특발적 백내장 약제 제조를 위한 칼시토닌의 국소적용 용도 및 이의 약제학적 조성물
BR9808876A (pt)	2000-10-03	Sistema de liberação de medicamento

Legal Events

Date	Code	Title	Description
2010-03-08	MK1K	Patent expired